What are vaccine combination drugs?

vaccine combination drugs are pharmacologic agents that share a common mechanism. 3 are currently marketed, with 2 more in clinical development.

What are the marketed vaccine combination drugs?

Marketed vaccine combination drugs include COVAX+IIV4; COVAX+PPV23, Fluad and Prevenar13, immediate Cervarix, delayed MenVeo vaccine.

3 marketed 2 in Phase 3

This page covers all vaccine combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

COVAX+IIV4; COVAX+PPV23 · China National Biotec Group Company Limited · Immunology / Infectious Disease
COVAX+IIV4 and COVAX+PPV23 are combination vaccines that provide immunization against COVID-19 (COVAX component) alongside seasonal influenza (IIV4) or pneumococcal disease (PPV23).
Fluad and Prevenar13 · Korea University Guro Hospital · Immunology
This is a combination of two vaccines: Fluad (inactivated influenza vaccine) and Prevenar13 (pneumococcal conjugate vaccine) that stimulate immune responses against influenza and pneumococcal pathogens.
immediate Cervarix, delayed MenVeo vaccine · Massachusetts General Hospital · Immunology / Infectious Disease Prevention
This is a vaccination regimen combining two separate vaccines: Cervarix (HPV vaccine) given immediately and Menhibrix or Menveo (meningococcal vaccine) given on a delayed schedule to provide protection against human papillomavirus and meningococcal disease.

Infanrix + Prevenar 13 · University Hospital Tuebingen · Immunology
This is a combination vaccine that stimulates the immune system to produce antibodies against diphtheria, tetanus, pertussis, and 13 serotypes of Streptococcus pneumoniae.
ROTARIX + DPT-HepB-Hib + OPV · Serum Institute of India Pvt. Ltd. · Immunology / Infectious Disease Prevention
This combination vaccine provides immunization against rotavirus, diphtheria, pertussis, tetanus, hepatitis B, Haemophilus influenzae type b, and poliomyelitis through inactivated and live attenuated viral/bacterial antigens.